Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1663

BillFederalSenateIn Committee
Therapeutic Fraud Prevention Act of 2025
About This Bill
Committee
Latest Action · May 7, 2025
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Congress
119th (2025–2027)
Introduced
May 7, 2025
Sponsor
Sen. Patty MurrayD
Cosponsors (40)
38D 0R
View PDF ↗

Summary

Highlight any text to annotate
The Therapeutic Fraud Prevention Act of 2025 would prohibit the commercial practice of conversion therapy — treatments that claim to change someone's sexual orientation or gender identity. The bill defines conversion therapy as any paid practice or service designed to alter sexual orientation or gender identity, while excluding legitimate medical support for people undergoing gender transitions and counseling that focuses on acceptance and coping. The legislation would be enforced by the Federal Trade Commission as an unfair and deceptive trade practice, with the FTC, U.S. Attorney General, and state attorneys general all authorized to bring civil enforcement actions against violators. The bill is based on the congressional finding that major professional organizations have determined conversion therapy is ineffective and harmful, potentially contributing to depression, self-harm, and suicide. The bill contains no specific funding or implementation timeline beyond authorizing enforcement agencies to pursue violations through existing legal mechanisms.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.